Measuring the size of a treatment effect: Relative risk reduction, absolute risk reduction, and number needed to treat

Evidence-Based Ophthalmology

Volumn 11, Issue 1, 2010, Pages 4-8

  Hollands, Hussein ^a   Kertes, Peter J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; TRIAMCINOLONE ACETONIDE;

CLINICAL PRACTICE; DIABETIC MACULAR EDEMA; FOLLOW UP; GLAUCOMA; GLAUCOMA SURGERY; HUMAN; INTRAOCULAR HYPERTENSION; MEDICAL DECISION MAKING; PRIORITY JOURNAL; RISK REDUCTION; SHORT SURVEY; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 75749094459     PISSN: 15559203     EISSN: 15559211     Source Type: Journal    
DOI: 10.1097/01.IEB.0000367521.48831.78     Document Type: Short Survey

References (11)

1. Rosner B. Fundamentals of Biostatistics. 6th ed. Toronto: Thomson; 2006.
2. Kertes PJ, Johnson TM. Evidence-Based Eye Care. Philadelphia: Lippincott Williams & Wilkins; 2007.
3. Oxman AD, Sackett DL, Guyatt GH. Users' guides to themedical literature. I. Howto get started. The Evidence-BasedMedicineWorking Group. JAMA. 1993;270:2093-2095.
4. Sackett DL, Brian Haynes R, Tugwell P. Clinical Epidemiology a Basic Science for Clinical Medicine. Toronto: Little, Brown, and Company; 1988.
5. Oleckno W. Essential Epidemiology Principles and Applications. Prospect Heights, IL:Waveland Press; 2002.
6. Higginbotham EJ, Gordon MO, Beiser JA, et al. The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals. Arch Ophthalmol. 2004;122:813-820.
7. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary openangle glaucoma. Arch Ophthalmol. 2002;120: 701-713; discussion 829-830.
8. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab Versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432-1444.
9. Wilhelmus KR, Gee L, Hauck WW, et al. Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology. 1994;101:1883-1895; discussion 1895-1896.
10. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417-1436.
11. Gillies MC, Sutter FK, Simpson JM, et al. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Opthalmology. 2006;113:1533-1538.